FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281626825> ?p ?o ?g. }

• W4281626825 abstract "Abstract Background Intermittent fasting (IF), consisting of either a one-day (IF1) or two consecutive days (IF2) per week, is commonly used for optimal body weight loss. Our laboratory has previously shown an IF1 diet combined with 6d/week of protein pacing (P; 4–5 meals/day evenly spaced, ~ 30% protein/day) significantly enhances weight loss, body composition, and cardiometabolic health in obese men and women. Whether an IF1-P or IF2-P, matched for weekly energy intake (EI) and expenditure (EE), is superior for weight loss, body composition, and cardiometabolic health is unknown. Methods This randomized control study directly compared an IF1-P ( n = 10) versus an IF2-P ( n = 10) diet on weight loss and body composition, cardiovascular (blood pressure and lipids), hormone, and hunger responses in 20 overweight men and women during a 4-week weight loss period. Participants received weekly dietary counseling and monitoring of compliance from a registered dietitian. All outcome variables were assessed pre (week 0) and post (week 5). Results Both groups significantly reduced body weight, waist circumference, percent body fat, fat mass, hunger, blood pressure, lipids, glucose, and increased percent fat-free mass ( p < 0.05). However, IF2-P resulted in significantly greater reductions in body weight (-29%) and waist circumference (-38%) compared to IF1-P ( p < 0.05), and showed a strong tendency for greater reductions in fat mass, glucose, and hunger levels ( p < 0.10) despite similar weekly total EI (IF1-P, 9058 ± 692 vs. IF2-P, 8389 ± 438 kcals/week; p = 0.90), EE (~ 300 kcals/day; p = 0.79), and hormone responses ( p > 0.10). Conclusions These findings support short-term IF1-P and IF2-P to optimize weight loss and improve body composition, cardiometabolic health, and hunger management, with IF2-P providing enhanced benefits in overweight women and men. Trial registration This trial was registered March 03, 2020 at www.clinicaltrials.gov as NCT04327141 ." @default.
• W4281626825 created "2022-06-13" @default.
• W4281626825 creator A5001292004 @default.
• W4281626825 creator A5007342924 @default.
• W4281626825 creator A5016298024 @default.
• W4281626825 creator A5017337274 @default.
• W4281626825 creator A5019249351 @default.
• W4281626825 creator A5022810567 @default.
• W4281626825 creator A5023441238 @default.
• W4281626825 creator A5035764575 @default.
• W4281626825 creator A5050724065 @default.
• W4281626825 creator A5052630762 @default.
• W4281626825 creator A5055058010 @default.
• W4281626825 creator A5055174519 @default.
• W4281626825 creator A5055915667 @default.
• W4281626825 creator A5066088819 @default.
• W4281626825 creator A5067826363 @default.
• W4281626825 creator A5081008971 @default.
• W4281626825 date "2022-06-04" @default.
• W4281626825 modified "2023-10-17" @default.
• W4281626825 title "Intermittent fasting two days versus one day per week, matched for total energy intake and expenditure, increases weight loss in overweight/obese men and women" @default.
• W4281626825 cites W1967644678 @default.
• W4281626825 cites W2007060126 @default.
• W4281626825 cites W2014106175 @default.
• W4281626825 cites W2015185489 @default.
• W4281626825 cites W2018938149 @default.
• W4281626825 cites W2081923532 @default.
• W4281626825 cites W2102738910 @default.
• W4281626825 cites W2118559133 @default.
• W4281626825 cites W2131778326 @default.
• W4281626825 cites W2135997989 @default.
• W4281626825 cites W2138867816 @default.
• W4281626825 cites W2140595199 @default.
• W4281626825 cites W2141308679 @default.
• W4281626825 cites W2143022335 @default.
• W4281626825 cites W2147127395 @default.
• W4281626825 cites W2153992901 @default.
• W4281626825 cites W2159999083 @default.
• W4281626825 cites W2169058642 @default.
• W4281626825 cites W2206659309 @default.
• W4281626825 cites W2321372559 @default.
• W4281626825 cites W2496580996 @default.
• W4281626825 cites W2507230842 @default.
• W4281626825 cites W2527551486 @default.
• W4281626825 cites W2569082460 @default.
• W4281626825 cites W2747197555 @default.
• W4281626825 cites W2766781761 @default.
• W4281626825 cites W2795033987 @default.
• W4281626825 cites W2906663197 @default.
• W4281626825 cites W2921359643 @default.
• W4281626825 cites W2947106737 @default.
• W4281626825 cites W2963930807 @default.
• W4281626825 cites W2965735635 @default.
• W4281626825 cites W2971652046 @default.
• W4281626825 cites W2991261186 @default.
• W4281626825 cites W2996467470 @default.
• W4281626825 cites W2998467274 @default.
• W4281626825 cites W3009892799 @default.
• W4281626825 cites W3010443092 @default.
• W4281626825 cites W3014325269 @default.
• W4281626825 cites W3042352952 @default.
• W4281626825 cites W3118823990 @default.
• W4281626825 cites W3133951938 @default.
• W4281626825 cites W3137037404 @default.
• W4281626825 cites W3170923425 @default.
• W4281626825 cites W3179155237 @default.
• W4281626825 cites W3200181038 @default.
• W4281626825 cites W3205251799 @default.
• W4281626825 cites W3205293503 @default.
• W4281626825 cites W3206028136 @default.
• W4281626825 cites W4210629503 @default.
• W4281626825 doi "https://doi.org/10.1186/s12937-022-00790-0" @default.
• W4281626825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35658959" @default.
• W4281626825 hasPublicationYear "2022" @default.
• W4281626825 type Work @default.
• W4281626825 citedByCount "7" @default.
• W4281626825 countsByYear W42816268252022 @default.
• W4281626825 countsByYear W42816268252023 @default.
• W4281626825 crossrefType "journal-article" @default.
• W4281626825 hasAuthorship W4281626825A5001292004 @default.
• W4281626825 hasAuthorship W4281626825A5007342924 @default.
• W4281626825 hasAuthorship W4281626825A5016298024 @default.
• W4281626825 hasAuthorship W4281626825A5017337274 @default.
• W4281626825 hasAuthorship W4281626825A5019249351 @default.
• W4281626825 hasAuthorship W4281626825A5022810567 @default.
• W4281626825 hasAuthorship W4281626825A5023441238 @default.
• W4281626825 hasAuthorship W4281626825A5035764575 @default.
• W4281626825 hasAuthorship W4281626825A5050724065 @default.
• W4281626825 hasAuthorship W4281626825A5052630762 @default.
• W4281626825 hasAuthorship W4281626825A5055058010 @default.
• W4281626825 hasAuthorship W4281626825A5055174519 @default.
• W4281626825 hasAuthorship W4281626825A5055915667 @default.
• W4281626825 hasAuthorship W4281626825A5066088819 @default.
• W4281626825 hasAuthorship W4281626825A5067826363 @default.
• W4281626825 hasAuthorship W4281626825A5081008971 @default.
• W4281626825 hasBestOaLocation W42816268251 @default.
• W4281626825 hasConcept C126322002 @default.
• W4281626825 hasConcept C134018914 @default.
• W4281626825 hasConcept C140793950 @default.
• W4281626825 hasConcept C148257392 @default.

• next